594 related articles for article (PubMed ID: 28669836)
1. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
[TBL] [Abstract][Full Text] [Related]
2. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
[TBL] [Abstract][Full Text] [Related]
4. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
5. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.
Celik IH; Oguz SS; Demirel G; Erdeve O; Dilmen U
Eur J Pediatr; 2012 Feb; 171(2):311-6. PubMed ID: 21809011
[TBL] [Abstract][Full Text] [Related]
6. Inhaled colistin for lower respiratory tract infections.
Antoniu SA; Cojocaru I
Expert Opin Drug Deliv; 2012 Mar; 9(3):333-42. PubMed ID: 22332963
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
8. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
[TBL] [Abstract][Full Text] [Related]
9. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Korbila IP; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485
[TBL] [Abstract][Full Text] [Related]
10. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
[TBL] [Abstract][Full Text] [Related]
11. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Kwa AL; Loh C; Low JG; Kurup A; Tam VH
Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
[TBL] [Abstract][Full Text] [Related]
14. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
[TBL] [Abstract][Full Text] [Related]
15. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
[TBL] [Abstract][Full Text] [Related]
16. Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis.
Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
J Infect; 2018 Apr; 76(4):321-327. PubMed ID: 29428226
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
18. Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
Int J Antimicrob Agents; 2018 Apr; 51(4):535-547. PubMed ID: 29288723
[TBL] [Abstract][Full Text] [Related]
19. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
20. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]